Evaluation of Tamoxifen and Simvastatin as the Combination Therapy for the Treatment of Hormonal Dependent Breast Cancer cells
In conclusion, our results suggest that SIM may serve as a promising treatment with TAM for improving the efficacy against estrogen receptor-positive (ER+) breast cancer.Graphical abstract
Source: Toxicology Reports - Category: Toxicology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Hormones | Simvastatin | Statin Therapy | Study | Tamoxifen | Toxicology | Zocor